Towards Cardiac Risk Monitoring of Duchene Muscular Dystrophy using Lyfas

Authors

  • Rupam Das Dept. of Research and Development (Digital Health), Acculi Labs Pvt. Ltd., Bangalore 560098, Karnataka India
  • Subhagata Chattopadhyay Dept. of Research and Development (Digital Health), Acculi Labs Pvt. Ltd., Bangalore 560098, Karnataka India

DOI:

https://doi.org/10.12974/2311-8792.2021.07.3

Keywords:

Duchene muscular dystrophy, Digital biomarkers, Time-series study, Lyfas

Abstract

Duchene Muscular Dystrophy (DMD) is a progressive neuromuscular disorder affecting male children of a career mother, as seen in more than 70% of cases. It is an X-linked recessive disease that affects 1 in 3600-6000 live male births. As the child grows, muscles are progressively wasted and degenerated in the body. As time passes, it also involves intercostal and heart muscles leading to cardiorespiratory failure and death. Using a smartphone-based application namely, Lyfas that uses the principles of the optical sensor, arterial photoplethysmography, and photochromatography, this report focuses on capturing digital cardiovascular biomarkers at the backdrop of DMD and understanding the physiological aspect of the disorder and its progression, especially the risk of the involvement of cardiac muscles.

References

D. Duan, N. Goemans, S. Takeda, E. Mercuri and A. Aartsma-Rus, "Duchenne muscular dystrophy," Nature Reviews Disease Primers 2021; 7: p. 13,. https://doi.org/10.1038/s41572-021-00248-3

M. Basu, "A breakthrough for a rare genetic disorder," downtoearth, 08 Jan 2020.

[Online]. Available: https://www.downtoearth.org.in/interviews/health/abreakthrough- for-a-rare-genetic-disorder-68447. [Accessed 21 Sept 2021].

G. Acsadi, "rarediseases.org," national Organization for Rare Disorders, 6 June 2016.

[Online]. Available: https://rarediseases.org/rare-diseases/duchenne-musculardystrophy/. [Accessed 21 Sept 2021].

P. Munot, N. McCrea, S. Torelli, A. Manzur, C. Sewry, D. Chambers, L. Feng, P. Ala, I. Zaharieva, N. Ragge, H. Roper, T. Marton, P. Cox, M. Milev, M. Sacher, W. Liang, S. Maruyama, I. Nishino, R. Phadke and F. Muntoni, "P.198 TRAPPC11-related muscular dystrophy with hypoglycosylation of alpha-dystroglycan in skeletal muscle and brain," Neuromuscular Disorders, 2020; 30(1): S46- S150. https://doi.org/10.21203/rs.3.rs-31937/v1

RS. Aujla and R. Patel, "Creatine Phosphokinase," in StatPearls, Treasure Island (FL), StatPearls Publishing LLC, 2021.

C. Tschöpe, E. Ammirati, B. Bozkurt, A. Caforio, LT. Cooper, SB. Felix, JM. Hare, B. Heidecker, S. Heymans, N. Hübner, S. Kelle, K. Klingel, H. Maatz, AS. Parwani, F. Spillmann, RC. Starling, H. Tsutsui and P. Seferovic, "Myocarditis and inflammatory cardiomyopathy: current evidence and future directions," Nature Review of Cardiology, 2021; 18: 169-193. https://doi.org/10.1038/s41569-020-00435-x

S. Shrestha and S. Munakomi, "StatPearls [Internet].," in Gower Sign , Treasure Island (FL): StatPearls Publishing; 2021 Jan, [Updated 2021 Feb 23].

SM. Szabo, R. Salhany, A. Deighton, M. Harwood, J. and KL. Gooch, "The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review," Orphanet Journal of Rare Diseases 2021; 16(237). https://doi.org/10.1186/s13023-021-01862-w

TD. da Silva, T. Massetti, TB. Crocetta, CB. de Mello Monteiro, A. Carll, LC. Marques Vanderlei, C. Arbaugh, FR. Oliveira, LC. de Abreu, CF. Filho, J. Godleski and C. Ferreira, "Heart Rate Variability and Cardiopulmonary Dysfunction in Patients with Duchenne Muscular Dystrophy: A Systematic Review," Pediatric Cardiology 2018; 39(5): 869-883. https://doi.org/10.1007/s00246-018-1881-0

Acculi Labs Pvt. Ltd., [Online]. Available: http://acculi.com/. [Accessed 25 October 2021].

HS. Deepa and R. Das, "Evaluation Of Non-Invasive Smartphone Based Digital Biomarker Tool Lyfas In Detecting Sleep Deficiency And Its Effects: A Retrospective Observational Study," Indian Journal of Applied Research 2021; 11(1): 46-47. https://doi.org/10.36106/ijar/6214476

MM. Corrales, BDLC. Torres, AG. Esquivel, MAG. Salazar and JN. Orellana, "Normal values of heart rate variability at rest in a young, healthy and active Mexican population," Health 2012; 4(7): 1-9.

CM. DeGiorgio, P. Miller, S. Meymandi, A. Chin, J. Epps, S. Gordon, J. Gornbein and R. Harper, "M. (2010). RMSSD, a measure of vagus-mediated heart rate variability, is associated with risk factors for SUDEP: the SUDEP-7 Inventory," Epilepsy & behavior 2010; 19(1): 78-81. https://doi.org/10.1016/j.yebeh.2010.06.011

K. Umetani, DH. Singer, R. McCraty and M. Atkinson, "Twenty-Four Hour Time Domain Heart Rate Variability and Heart Rate: Relations to Age and Gender Over Nine Decades," Journal of the American College of Cardiology, 1998; 31(3): 593-601. https://doi.org/10.1016/S0735-1097(97)00554-8

CS. Fazlı and E. Çelik, "Pediatric Heart Rate Variability Normative Values Related to Average Heart Rate and Age in a Developing Country," Online Journal of Cardiology Research & Reports, 2019; 2(5). https://doi.org/10.33552/OJCR.2019.02.000547

F. Shaffer and JP. Ginsberg, "An Overview of Heart Rate Variability Metrics and Norms," Frontiers in Public Health 2017; 28(5): 258. https://doi.org/10.3389/fpubh.2017.00258

G. Acsadi, "rare disease.org," National Organisation for rare disorders, 6 6 2016. [Online]. Available: https://rarediseases.org/rare-diseases/duchenne-musculardystrophy/. [Accessed 23 9 2021].

Downloads

Published

2021-10-31

How to Cite

Das, R., & Chattopadhyay, S. (2021). Towards Cardiac Risk Monitoring of Duchene Muscular Dystrophy using Lyfas. Journal of Nanotechnology in Diagnosis and Treatment, 7, 25–32. https://doi.org/10.12974/2311-8792.2021.07.3

Issue

Section

Articles